How common chlamydia and Mycoplasma genitalium infections are in the U.S.
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance
This project measures how often chlamydia and Mycoplasma genitalium affect people in the United States and how that information could change screening and antibiotic choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11075211 on NIH RePORTER |
What this research studies
From your perspective, researchers will combine national surveillance records, population-based samples, and laboratory testing to estimate how many people have these infections, including groups that are not routinely screened. They will examine symptoms, prior testing, and patterns of antibiotic resistance in the bacteria. The team will compare what they find to current screening recommendations to identify gaps in who gets tested. They may also analyze leftover clinical samples or survey participants to improve estimates for Mycoplasma genitalium.
Who could benefit from this research
Good fit: Ideal candidates would be sexually active adults in the U.S., especially women aged 25 and older and men who have sex with women who are not routinely screened.
Not a fit: People who are not sexually active or who have no risk factors for sexually transmitted infections are unlikely to receive direct benefit from this work.
Why it matters
Potential benefit: If successful, the findings could lead to clearer screening recommendations and smarter antibiotic use that reduce missed infections and slow resistance.
How similar studies have performed: Chlamydia surveillance and screening are well established, but population-level data and resistance information for Mycoplasma genitalium are limited, so parts of this work are relatively new.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Manhart, Lisa E — University of Washington
- Study coordinator: Manhart, Lisa E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.